Trademark: 79211993
Word
NEORESIST
Status
Registered
Status Code
700
Status Date
Tuesday, March 13, 2018
Serial Number
79211993
Registration Number
5420630
Registration Date
Tuesday, March 13, 2018
Mark Type
4000
Filing Date
Wednesday, January 25, 2017
Published for Opposition
Tuesday, December 26, 2017

Trademark Owner History
Siemens Healthcare GmbH - Original Registrant

Classifications
5 Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratories, namely, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, namely, for the detection, analysis and treatment of cancer; cultures of microorganisms for medical and veterinary use
44 Medical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases
42 Scientific and technological services, namely, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software

Trademark Events
Mar 13, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 24, 2021
New Representative At Ib Received
Jul 14, 2018
Final Decision Transaction Processed By Ib
Jun 15, 2018
Final Disposition Notice Sent To Ib
Jun 15, 2018
Final Disposition Processed
Jun 13, 2018
Final Disposition Notice Created, To Be Sent To Ib
Mar 13, 2018
Registered-Principal Register
Dec 26, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2017
Published For Opposition
Dec 22, 2017
Notification Processed By Ib
Dec 6, 2017
Notification Of Possible Opposition Sent To Ib
Dec 6, 2017
Notification Of Notice Of Publication E-Mailed
Dec 6, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 17, 2017
Approved For Pub - Principal Register
Nov 6, 2017
Teas/Email Correspondence Entered
Nov 6, 2017
Correspondence Received In Law Office
Nov 1, 2017
Assigned To Lie
Oct 23, 2017
Teas Response To Office Action Received
Aug 11, 2017
Refusal Processed By Ib
Jul 27, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Jul 27, 2017
Refusal Processed By Mpu
Jul 22, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jul 21, 2017
Non-Final Action Written
Jul 18, 2017
Application Filing Receipt Mailed
Jul 14, 2017
Assigned To Examiner
Jul 14, 2017
New Application Office Supplied Data Entered
Jul 13, 2017
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24